Journal article icon

Journal article

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial

Abstract:

Previous preclinical research has shown that extracorporeal devices can be used to enhance the delivery and distribution of systemically administered anticancer drugs, resulting in increased intratumoural concentrations. We aimed to assess the safety and feasibility of targeted release and enhanced delivery of doxorubicin to solid tumours from thermosensitive liposomes triggered by mild hyperthermia, induced non-invasively by focused ultrasound.We did an open-label, single-centre, phase 1 tri...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1016/s1470-2045(18)30332-2

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Surgical Sciences
ORCID:
0000-0002-8432-5771
More by this author
Institution:
University of Oxford
Division:
MPLS Division
Department:
Engineering Science
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Expand authors...
National Institute for Health Research More from this funder
Publisher:
Elsevier Publisher's website
Journal:
Lancet Oncology Journal website
Volume:
19
Issue:
8
Pages:
1027-1039
Publication date:
2018-07-11
Acceptance date:
2018-04-20
DOI:
EISSN:
1470-2045
ISSN:
1474-5488
Pubs id:
pubs:889877
URN:
uri:114c2816-9ca6-49a3-aeea-003f942e8ac1
UUID:
uuid:114c2816-9ca6-49a3-aeea-003f942e8ac1
Local pid:
pubs:889877
Language:
English
Keywords:

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP